• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Ray Dalio Warns of Market Bubble Amid US Money Printing

chest

Ray Dalio warns of a potential market bubble due to US money printing, highlighting risks of high asset valuations and fiscal deficits.

user avatarLuis Flores

BRICS Nations Accelerate De-Dollarization Efforts

chest

BRICS nations are increasing gold purchases to reduce reliance on the US dollar, acquiring 166 tonnes in Q2 2025, marking a 41% increase above historical averages.

user avatarArif Mukhtar

RealFi to Launch Real Token, Connecting Real Estate Market to XRP Ledger

chest

RealFi is set to launch its Real Token on December 5, 2025, on a centralized exchange, connecting the real estate market to the XRP Ledger.

user avatarMaria Gutierrez

MEXC Launches STABLE Launchpad Event for Token Subscriptions

chest

MEXC launches STABLE Launchpad event, offering early access to 4 million STABLE tokens through two subscription pools with discounts up to 60%.

user avatarAndrew Smith

Bitcoin Surges Past 94,000 After Recent Crash

chest

Bitcoin's price rebounded impressively, briefly exceeding 94,000 after a significant drop earlier in the week.

user avatarDavid Robinson

PC Coin's Referral Rewards Program Encourages Community Growth

chest

PC Coin's Referral Rewards Program incentivizes users to expand the community by offering rewards for referrals.

user avatarBayarjavkhlan Ganbaatar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.